European Parliament Clears Marketing Exclusivity For Pediatric Testing

Law360, New York (September 7, 2005, 12:00 AM EDT) -- The European Parliament has approved a proposal to extend patent protection on some drugs in return for pediatric research.

The proposal will require new drugs to be tested specifically on children before they are cleared for pediatric use, and aims to stimulate new research into existing medicines.

Under the proposal, most pediatric drugs would receive an additional six months of patent protection. Other drugs, used for extremely rare diseases, would be patented for two extra years.

The proposal would require new drugs to be tested specifically...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.